NCT02427191 - Micronized dHACM Injectable for the Treatment of Plantar Fasciitis | Biotech Hunter

Enrollment

147

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions

Fasciitis, Plantar

Interventions

OTHER

AmnioFix® Injectable

1 mL injection of 40 mg Micronized dehydrated human amnion/chorion membrane (dHACM)

DRUG

Saline Injection

Injection of 1mL 0.9% Sodium Chloride Injection, USP

Trial Locations (11)

Timonium Foot and Ankle Center, Baltimore

MedStar Union Memorial Hospital, Baltimore

Coastal Podiatry Group, Virginia Beach

WJB Dorn VA Medical Center, Columbia

Orlando VA Healthcare System, Orlando

James A. Lovell Federal Health Care Center, North Chicago

Edward Hines Jr. Veterans Administration Hospital, Chicago

Scott & White Healthcare, Temple

Southern Arizona VA Health Care System, Tucson

Limb Preservation Platform, Inc., Fresno

Center for Clinical Research, Inc., San Francisco

All Listed Sponsors

lead

MiMedx Group, Inc.

INDUSTRY